Abstract
Periodontal tissue is a distinctive tissue structure composed three-dimensionally of cementum, periodontal ligament (PDL) and alveolar bone. Severe periodontal diseases cause fundamental problems for oral function and general health, and conventional dental treatments are insufficient for healing to healthy periodontal tissue. Cell sheet technology has been used in many tissue regenerations, including periodontal tissue, to transplant appropriate stem/progenitor cells for tissue regeneration of a target site as a uniform tissue. However, it is still difficult to construct a three-dimensional structure of complex tissue composed of multiple types of cells, and the transplantation of a single cell sheet cannot sufficiently regenerate a large-scale tissue injury. Here, we fabricated a three-dimensional complex cell sheet composed of a bone-ligament structure by layering PDL cells and osteoblast-like cells on a temperature responsive culture dish. Following ectopic and orthotopic transplantation, only the complex cell sheet group was demonstrated to anatomically regenerate the bone-ligament structure along with the functional connection of PDL-like fibers to the tooth root and alveolar bone. This study represents successful three-dimensional tissue regeneration of a large-scale tissue injury using a bioengineered tissue designed to simulate the anatomical structure.
Subject terms: Regenerative medicine, Tissue engineering
Introduction
Periodontal tissue is a specialized three-dimensional multicellular structure composed of cementum, periodontal ligament (PDL) and alveolar bone1. PDL can cooperate with the maxillofacial region through fibrous connections with the cementum and the alveolar bone, and it plays important roles in biological functions, including the absorption of occlusal forces, maintenance of alveolar bone height and tooth movement via bone remodelling2,3. Periodontal diseases cause fundamental problems for oral function due to a severe inflammatory reaction caused by bacterial infection or traumatic force4. Progressive periodontal disease can cause irreversible changes in the affected area, and if not treated it leads to tooth loss, dysfunction and thereby affects the quality of life5. Conventional dental treatments for periodontal disease, such as scaling and root planing, have been widely utilized in clinical practice to mechanically remove the source of the infection. However, it commonly results in the formation of long junctional epithelium on the root surface and the damaged periodontal tissue is difficult to heal with only these mechanical approaches6. To regenerate healthy periodontal tissue, various clinical techniques were developed to prevent downward epithelial migration and promote periodontal tissue regeneration by the remaining PDL cells or osteoblasts. Guided tissue regeneration (GTR) and guided bone regeneration (GBR) have been used in various membranes to create a three-dimensional space between the defect and root/bone surface to allow the repopulation of cells, and thereby regeneration of PDL and bone tissue. Although these techniques are effective in current dental treatment, a long-term stable clinical outcome has not been attained7,8.
Recent advances in regenerative medicine have been supported by studies in embryonic development, stem-cell biology and tissue engineering technology9,10. Stem-cell transplantation and cytokine therapy, which target structural and functional defects are considered regenerative concepts for the repair of damaged tissues11,12. In the dental research field, tooth-tissue derived stem cells, adipose-derived stem cells and cytokines have been well characterised, and the information can be applied to the repair of periodontal tissue components such as cementum, PDL and alveolar bone13,14. PDL-derived stem cells (PDLSCs) have been identified in adult human PDL tissue, and are able to differentiate into all of the periodontal tissue components and generate cementum and the PDL complex structure after in vivo transplantation2,15. Dental follicle stem cells (DFSCs) were identified as mesenchymal stem/progenitor cells in the first molars of neonatal rat, and they can differentiate into osteoblasts, cementoblasts, adipocytes, and neural cells16–18. Moreover, gingival tissue has been identified as a source of mesenchymal stem cells with the characteristics such as homogeneity of cells, easy to isolate and faster proliferation rate, which makes them a promising source for the regeneration field19–21. All these stem cells are considered a candidate cell source for periodontal tissue regeneration, and several molecular treatments can be administered via local application of recombinant cytokines, such as fibroblast growth factor-2 (FGF-2), transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein (BMP)22–24, to repair periodontal tissue injury. In addition, enamel matrix derivative (EMD) has been applied clinically to restore periodontal tissues25,26. These molecular treatments have great potential for periodontal tissue regeneration through the stimulation of signaling pathways associated with cell proliferation and differentiation. However, the limitation of cell transplantation and cytokine therapy includes the difficulty in delivering and stabilizing a sufficient quantity of cells/molecules into the defect area13. Furthermore, tissue engineering is an attractive approach introduced in the field of periodontal tissue regeneration. Tissue engineering utilizes various porous scaffolds made of biomaterials to regenerate periodontal tissue around tooth and dental implants27–29.
Cell sheet engineering with a temperature responsive culture dish has various advantages over the regenerative methods using artificial scaffolds. Cells can be harvested as a single sheet without destroying the cellular attachment proteins and extracellular matrix30. Scaffold-free cell sheet engineering has been applied in regeneration of such tissues as cornea, heart, esophagus, cartilage, liver and periodontal31. A PDL cell sheet for the regeneration of periodontal tissue is now at the stage of clinical therapy for periodontal disease32. Although this technology contributes to partial tissue repair, a single cell sheet cannot sufficiently regenerate a large-scale tissue injury33. To solve this problem, some researchers have tried to use a combination of multiple cell sheets and artificial scaffolds including more than one type of cell34–38. Even though these biomaterials have shown preliminary successful regeneration of periodontal tissue, they still include a non-living artificial material, and the long-term biological response following the implantation of such materials are still questionable37. An ideal goal of tissue engineering technologies is the application of a well-designed bioengineered tissue without artificial materials that simulate anatomical structure, to enable a complete three-dimensional tissue regeneration for a large-scale tissue injury area38.
In this study, we demonstrated a three-dimensional regeneration of periodontal tissue using a complex cell sheet composed of PDL cells and osteoblast-like cells. Our complex cell sheet anatomically reproduced bone-ligament structure equivalent to natural periodontal tissue in in vivo transplantation. This study highlights a successful three-dimensional tissue regeneration of a large-scale tissue injury using a bioengineered tissue designed to simulate the anatomical structure.
Results
In vitro characteristics of cells
We have used two types of cells for the fabrication of cell sheets, which includes, rat PDL cells and osteoblast like cells (MC3T3-E1cells). PDL cells were isolated from the extracted molars of 4–5 weeks old SD rats. Mouse calvaria derived MC3T3-E1 cells were obtained from Riken industry, Japan. The cell morphology was identified under a light microscope. Rat PDL cells exhibited a fusiform and spindle shaped morphology (Fig. 1A,B). MC3T3-E1 cells showed a polygonal and fusiform shape (Fig. 1C,D). Semi-quantitative PCR and agarose gel electrophoresis was carried out to identify the genes related to each cell type. Rat PDL cells exhibited a positive expression related to the collagen type 3, alpha 1 (col3a1), β-actin, collagen type I, alpha 2 (col1a2), growth differentiation factor 7 (GDF-7), scleraxis, periostin, tenascin C, fibronectin 1, β1-integrin, cementum attachment protein (CAP) and f-spondin, low intensity bands were observed for alkaline phosphatase (ALP), runt related transcription factor-2 (Runx-2) and osteocalcin (OCN) genes by RT-PCR and agarose gel electrophoresis (Fig. 1E). Similarly, MC3T3-E1 cells showed positive gene expression for col3a1, β-actin, col1a2, periostin, tenascin C, fibronectin 1, β1-integrin, CAP, ALP, Runx-2 and OCN. Furthermore, GDF-7 and f-spondin did not show any expression for MC3T3-E1 cells(Fig. 1F).
In vitro analysis of three different cell sheets
Three types of cell sheets were prepared for the study (Supplementary data, Fig. S1), two single cell sheets containing either PDL cells (PDL cell sheet) or MC3T3-E1 cells (MC3T3-E1 cell sheet) and a complex cell sheet containing both cells. All cell sheets were fabricated by culturing in a temperature responsive culture dish. The morphology of the cell sheets was observed using light microscope (Fig. 2B,E,H), and a stereomicroscope (Fig. 2A‚D,G). The complex cell sheet (Fig. 2G) appeared thicker than either the MC3T3-E1 cell sheet (Fig. 2A) or PDL cell sheet (Fig. 2D). The marginal edges of the complex cell sheets were rolled in toward the side of the PDL cells layer (Fig. 2G). This was an advantageous identification in our study, which was later used to orient the PDL cell side towards the tooth root in ectopic and orthotopic transplantation of cell sheets. H&E staining of the cell sheets revealed that the MC3T3-E1 cell sheet and PDL cell sheets were composed of 3 to 4 layers of cells (Fig. 2C,F). Alternatively, the complex cell sheets resulted in around 10 layers of cells (Fig. 2I). Furthermore, to identify distinct layers of 2 types of cells in complex cell sheet, we performed immunohistochemistry using anti-mouse-OCN antibody and species specific fluorescent in situ hybridization (FISH) probe for rat cells. Immunohistochemical analysis of cell sheets by anti-mouse-OCN antibody shows a positive expression in MC3T3-E1 cell sheet (Fig. 3A) and the MC3T3-E1 cell area in complex cell sheet (Fig. 3C, PDL cells and MC3T3-E1 cells area is demarcated using black dotted lines). PDL cell sheet and PDL cell area in complex cell sheet did not express a positive staining against anti-mouse-OCN antibody (Fig. 3B,C). As we have used anti-mouse-OCN antibody, the negative expression in rat PDL cell layer does not necessarily indicate the absence of OCN expression by PDL cells. Furthermore, species specific FISH probe for rat species showed an immunoreactivity against rat PDL cells and there was a negative reaction in MC3T3-E1 cell side in complex cell sheet (Fig. 3D, PDL cells and MC3T3-E1 cells area is demarcated using yellow dotted lines). Thereby, the immunohistochemical staining against anti-mouse-OCN antibody and species specific FISH probe for rat species showed the distinct layers of mouse and rat cell area in complex cell sheet (Fig. 3C,D). In addition, we have done alizarin red staining of complex cell sheets to evaluate the formation of any mineralized nodules. Complex cell sheets did not form any mineral nodules prior to the in vivo transplantation of cell sheet (Fig. 3E).
The complex cell sheet promoted the generation of periodontal tissue in ectopic transplants
We next investigated whether the cell sheets could generate periodontal tissue around the carrier tooth root after ectopic transplantation in the subrenal capsule of immunocompromised mice. We used extracted, enzymatically digested and autoclaved mouse mandibular tooth (devoid of any cells) as a carrier to support the cell sheet. The carrier tooth was enveloped with the cell sheet, inserted into a collagen gel and the construct including carrier tooth, cell sheet and collagen gel was then transplanted into the subrenal capsule of mice (Supplementary data, Fig. S2). Four groups were included for ectopic transplantation. The control group (n = 4) was a tooth without a cell sheet. The treatment groups were a MC3T3-E1 cell sheet (n = 4), PDL cell sheet (n = 10) or complex cell sheet (n = 10) wrapped around the carrier tooth root and embedded in collagen gel. After 4 weeks of ectopic transplantation of cell sheets, we harvested the specimens and analyzed the generated tissue morphological characteristics using H&E staining, azan staining and immunohistochemistry under light microscope. H&E and azan staining revealed the presence of collagen gel structure around the carrier tooth without any tissue formation in the control group that was transplanted without any cell sheets (Fig. 4A–D). Bone-like tissue attached directly onto the tooth root was observed in the MC3T3-E1 cell sheet group (Fig. 4E–H), whereas the PDL cell sheet group produced an irregularly arranged fibrous tissue and weak attachment of this tissue to the tooth root (Fig. 4I–L). Alternatively, a combination of PDL-like and bone-like tissue formation was evident in the complex cell sheet group (Fig. 4M,N). There was a clear demarcation between PDL and bone-like tissue in the complex cell sheet group (shown by black dotted lines in Fig. 4M,N). Using azan staining, we have observed PDL-like fibers and newly formed bone-like tissue in the complex cell sheet group (Fig. 4O,P, PDL-like and bone-like tissue demarcation is shown by yellow dotted lines in Fig. 4O).
Furthermore, we performed immunohistochemistry analysis using anti-periostin and anti-mouse-OCN antibody to confirm the formation of PDL-like and bone like tissue. Immunohistochemistry staining revealed the expression of periostin in PDL cell sheet group (Fig. 5B) as well as in the PDL-like tissue area of complex cell sheet group (Fig. 5C). Moreover, periostin expression was lacking in transplants from MC3T3-E1 group (Fig. 5A) and the bone-like tissue area in complex cell sheet transplants (Fig. 5C, tissue demarcation is indicated using black dotted lines). On the other hand, immunohistochemistry staining using anti-mouse-OCN antibody revealed the localization of OCN in the MC3T3-E1 and complex cell sheet groups (Fig. 5D‚F). The MC3T3-E1 cell sheet transplants showed ankylosis of the tooth root with direct attachment of bone tissue and an absence of fibers attached to the tooth root (Fig. 5D). Complex cell sheet group revealed positive OCN expression in the bone-like tissue generated area (Fig. 5F, PDL-like and bone-like tissue demarcation is indicated using red dotted lines). As the PDL cell sheet group and PDL-like tissue area in complex cell sheet group is generated from rat PDL cells, it lacked positive reaction towards the anti-mouse-OCN antibody (Fig. 5E,F).
Complex cell sheet transplants revealed the expression of periostin in PDL-like tissue generated area and OCN expression in bone-like tissue generated area, which in turn indicates the formation of periodontal tissue like structure following ectopic transplantation of complex cell sheet.
Complex cell sheet promotes the regeneration of periodontal tissue in orthotopic transplants
Finally, to analyze the regenerative capacity of cell sheets in an orthotopic model, we created a periodontal tissue injury model mouse to accommodate the cell sheet. Injury was confining to the palatal surface of maxillary first molar tooth. We removed the periodontal ligament fibers and bone and created the defect with a size of 2 mm in length (anterior-posterior direction), 0.5 mm in width (buccal-palatal direction) and 1.5 mm in depth (Supplementary data, Fig. S3A,B). Five groups were categorized in orthotopic transplantation to observe periodontal tissue regeneration. The groups were natural periodontal tissue (n = 4), a periodontal tissue injury model (n = 4), control group (without any cell sheet transplantation) after 8 weeks (n = 6), a PDL cell sheet transplanted group after 8 weeks (n = 6) and complex cell sheet transplanted group after 8 weeks (n = 6).
The three-dimensional images of micro-CT evaluation demonstrated the natural periodontal tissue structure near the palatal surface of maxillary first molar tooth (Fig. 6A), periodontal tissue injury model on the palatal surface of maxillary first molar tooth (Fig. 6B, red arrow shows the periodontal tissue injury area), control (without any cell sheet transplantation) after 8 weeks (Fig. 6C) and the PDL and complex cell sheet transplant groups after 8 weeks (Fig. 6D,E). There was incomplete regeneration of mineralized tissue in the control group transplants (Figs. 6C and S4, blue arrow shows the area which is not regenerated) and PDL cell sheet group (Figs. 6D and S4, blue arrow shows the area which is not regenerated) after 8 weeks of orthotopic transplantation. Alternatively, a complete recovery of periodontal tissue injury with a newly formed mineralized tissue was observed in the complex cell sheet transplanted group (Figs. 6E and S4, yellow arrow heads), which was similar to the natural periodontal tissue (Fig. 6A). Furthermore, the regenerated bone volume (bone volume/tissue volume; BV/TV) at the periodontal tissue injury was calculated using the reconstructed three dimensional images. There was no significant difference in bone volume between complex cell sheet group and natural periodontal tissue group. In contrast, there was a significant difference in the bone volume in PDL cell sheet and control group compared to the complex cell sheet group (Fig. 6F). Abundant formation of mineralized tissue with an appropriate PDL space was observed in three-dimensional coronal sections at the anterior, middle and posterior portions of the tooth and the injury site in the complex cell sheet transplanted group (Fig. S5E, yellow arrow heads) similar to the normal structure (Fig. S5A). However, partial recovery of the defects with mineralized matrix was observed in the transplants from control group (Fig. S5C) and PDL cell sheet groups following 8 weeks (Fig. S5D).
Histological images of the natural architecture of periodontal tissue and an injury model created on day 1 by removing the PDL and bone tissue are shown in Fig. 7A–H.
An evident downward growth of epithelial tissue layer with the absence of any bone like tissue formation was observed with the H&E and azan staining of the transplants from the control group (Fig. 7I–L, shown in black arrow heads). There was an irregular arrangement of fibrous tissue with the absence of bone-like tissue formation was observed in the PDL cell sheet group (Fig. 7M–P). H&E staining revealed PDL-like fibers and bone-like tissue formation in the complex cell sheet group (Fig. 7Q,R). Azan staining revealed the functional connection of PDL-like fibers to the root surface equivalent to the natural PDL (Fig. 7S,T, shown in black arrows). Furthermore, there was a clear demarcation between the PDL space and bone-like tissue formation similar to natural periodontal tissue (Fig. 7R,S, separated with a black dotted line in the H&E image and yellow dotted line in the azan staining image).
Finally, we performed immunohistochemistry analysis using anti-periostin and anti-mouse-OCN antibody to confirm the formation of PDL-like and bone-like tissue formation in the orthotopic transplants. Immunohistochemistry staining revealed the presence of periostin in PDL of natural periodontal tissue (Fig. 8A). There was no significant staining against anti-periostin antibody in periodontal tissue injury model (Fig. 8B). Moreover, a weak periostin expression was observed in transplants from control group and PDL cell sheet group (Fig. 8C,D). Furthermore, a strong expression against anti-periostin antibody in the PDL area and negative expression of periostin in the regenerated bone tissue area was observed in complex cell sheet group (Fig. 8E, tissue demarcation is indicated using red dotted lines). In contrast, immunohistochemistry staining using anti-mouse-OCN antibody revealed the presence of OCN in the PDL as well as bone tissue in natural periodontal tissue (Fig. 8F). No significant staining was observed in periodontal tissue injury model (Fig. 8G). The transplants from control group lacked any positive reaction towards anti-mouse OCN antibody (Fig. 8H). As the PDL cell sheet group and PDL-like tissue area in complex cell sheet group is regenerated from rat PDL cells, it lacked positive reaction towards the anti-mouse-OCN antibody (Fig. 8I,J). Alternatively, the complex cell sheet group revealed positive OCN expression in the bone-like tissue regenerated area (Fig. 8J, PDL-like and bone-like tissue demarcation is indicated using black dotted lines). These results indicate the regeneration of three-dimensional periodontal tissue like structure equivalent to the architecture of layered bone-ligament construct/ complex cell sheet.
Discussion
In this study, we fabricated a complex cell sheet composed of PDL cells and osteoblast-like cells that reproduce the bone-ligament structure equivalent to natural periodontal tissue. We also demonstrated a three-dimensional regeneration of periodontal tissue using a complex cell sheet in ectopic and orthotopic transplantation. This study represents the feasibility of a three-dimensional tissue engineering/regeneration from an anatomically designed bioengineered complex tissue.
Cell sheet technology has a great advantage in that it can transplant appropriate stem/progenitor cells for tissue regeneration of target site as a uniform tissue, and can be used clinically for diseases and injuries in various tissues31,32. Different types of cell sheets, such as cartilage, esophagus epithelium and myocardium, can be easily made using tissue-derived stem/progenitor cells39–41, and a current advance in this field can create transplantable cell sheets, including retinal pigment epithelium and corneal epithelium, using the induced pluripotent stem (iPS) cells42,43. However, a substantial issue in cell sheet technology is that it is still difficult to construct a three-dimensional structure of complex tissue composed of multiple cell types33. Periodontal tissue, which is composed of cementum, PDL and alveolar bone, is a characteristic complex tissue with a bone-ligament interface. This anatomical architecture consists a functional connection between a hard tissue and ligament structure, which enables physiological tooth function, such as the ability to alleviate excessive occlusal force, to undergo orthodontic movement via bone remodelling and perceive noxious stimulations2,3. In our study transplantation of PDL cell sheets regenerated with an irregularly arranged fibrous tissue formation. PDL cells consists of a group of heterogeneous cell population and consist of several cell subsets and it is known that PDL cells produce osteoblast‐related extracellular matrix proteins44. However, previously it was shown that there was no mineralized tissue formation in cells cultured without an osteogenic induction medium45. Likewise, in this study we have not used a differentiation medium for periodontal ligament cell culture or cell sheet. Our prime focus was to analyze and demonstrate the possibility of simultaneous regeneration of PDL area from PDL cells and bone area from osteoblast-like cells from a complex cell sheet fabricated using multistage layering in a temperature responsive culture dish.
A proper periodontal tissue reconstruction around the dental implant has been demonstrated with a vertical alveolar bone regeneration using the dental follicle tissues in which the layered cell differentiation has occurred46. For the functional regeneration of periodontal tissue, several studies indicated the importance of a biological cross-talk between bone cells and PDL cells through the fabrication of a composite cell sheet by mixing both cells47,48. In addition, an attractive transplantation method with the combination of multiple types of uniform cell sheets has been attempted to reproduce the periodontal tissue structure; however, the complete complex structure of natural periodontal tissue is not established49. In this study, we fabricated a complex cell sheet composed of bone-ligament structure by layering PDL cells and osteoblast-like cells on a temperature responsive culture dish (Figs. 2 and 3 and Supplementary data, Fig. S1). Furthermore, our complex cell sheet developed a periodontal tissue structure equivalent to natural periodontal tissue in the ectopic/orthotopic transplantation (Figs. 4–8 and Supplementary data, Figs. S4 and S5). The complex cell sheet method could be used to construct a functional bone-ligament structure as a novel technology for three-dimensional tissue regeneration.
Recent progress in regenerative technologies, which can innovate the conventional medical treatments, have been developed by incorporating stem cell biology and biomaterial sciences50. In the dental field, the leading technologies, such as stem cell transplantation using tissue-derived cells, cytokine therapy and scaffold engineering, have been developed, and they can be applied clinically as an effective regenerative therapy for diseases and injuries in the maxillofacial region including teeth, periodontal tissue and jaw bones51,52. Cell sheet technology can develop a three-dimensional regenerative tissue without artificial materials, and this scaffold-free tissue engineering has been applied clinically to various tissue regenerations53,54. However, a single cell sheet cannot sufficiently regenerate a large-scale tissue injury and the current technology using a uniform cell sheet has a limitation in achieving the defect size to be regenerated33. Many researchers and clinicians have tried to develop combination methods with uniform cell sheets and various absorbable/non-absorbable artificial scaffolds for large-scale periodontal tissue injury. The use of well-designed scaffolds, including a biphasic scaffold, fiber guiding scaffold and multiphase region-specific micro-scaffolds, were considered for three-dimensional periodontal tissue regeneration34,55,56. Scaffold-free tissue engineering for a large-scale defect enables complete three-dimensional tissue regeneration by applying bioengineered tissue designed to simulate exact anatomical structure. In this study, we demonstrated that our complex cell sheet laminated with PDL cells and osteoblast-like cells could achieve complete periodontal tissue regeneration including the surrounding alveolar bone in a large-scale periodontal tissue defect (Figs. 6–8). The regenerated periodontal tissue could reorganize the natural bone-ligament structure that had a functional connection with tooth root and alveolar bone (Figs. 7 and 8). This study illustrates that our complex cell sheet layered of the bone-ligament structure is a biological engineering technology that could regenerate a large-scale periodontal tissue injury without artificial materials.
The acquisition and efficient amplification of stem/progenitor cells for tissue regeneration is an essential issue for clinical application in the tissue engineering technology. In the dental field, several tooth tissue-derived stem cells have been identified, and PDLSCs and DFSCs are considered useful stem cell sources of periodontal tissue regeneration5,46. Furthermore, other stem cell sources including iPS cells, which are derived from the non-odontogenic cells, have been attempted for dental tissue regeneration57,58. For example, several studies carried out transfer of genes, such as bone morphogenic protein-2 and tumor necrosis factor-6, into iPS cells to induce differentiation of cells that could regenerate target tissue59–62. In addition, an effective method for functional periodontal tissue regeneration has been developed in combination with iPS cells and cytokines including EMD and growth/differentiation factor-563–65. However, in current dental treatments, PDL cells and osteoblasts are the available cell sources that can be collected from living tissue and transplanted into patients. Ideally, immunological problems with transplanted tissues would be prevented by autologous transplantation of patient’s own cells, and utilization of stem cells derived from patients is currently the first choice in regenerative therapies based on tissue engineering technology66–68. Even though we adopted the osteoblast-like cells (MC3T3-E1 cells) to represent the bone cells in this study, in the case of clinical application using our technology, we must consider the use of osteoblasts that can be collected from the patient’s bone tissue or induce from the bone marrow stromal cells and/or PDL cells. In addition, transplantation with an excessive number of cells in a large-scale periodontal tissue injury might cause necrosis of the graft by reduced blood supply and inflammation19. Although in our technology using a complex cell sheet layered with multilineage cells it is important to transplant a large number of cells as a lump into the defect site, it is necessary to consider the above-mentioned problems such as necrosis and inflammation of the transplanted tissue. A previous study prevented the necrosis of transplants using a unique cell-sheet that mixed PDL cells and human umbilical vein endothelial cells (HUVECs) for periodontal tissue regeneration along with the vascular supply34. In addition, attractive technologies have been developed to reduce or suppress the necrosis and inflammation at the transplantation site69,70. The integration of these techniques into the future studies may facilitate improved bioengineered tissue engineering for the regeneration of extensive periodontal tissue defects.
In summary, our study demonstrated the fabrication of a complex cell sheet composed of PDL cells and osteoblast-like cells that anatomically reproduced the bone-ligament structure equivalent to natural periodontal tissue. Furthermore, we demonstrated three-dimensional regeneration of periodontal tissue using a complex cell sheet in a large-scale tissue injury. This study represents the feasibility of three-dimensional tissue engineering/regeneration using an anatomically designed bioengineered complex tissue.
Materials and Methods
Animals
All animals were purchased from a licensed company (CLEA Japan, Osaka, Japan). We used 4–5-week-old male Sprague-Dawley (SD) rats for the PDL cell collection. C57BL male mice were used for collecting mandibular first molars that were later used as a carrier for ectopic transplantation. CB17/Icr scid/scid female mice were used for ectopic transplantation and orthotopic transplantation. All of the surgical procedures were carried out under general anesthesia using 75 mg/kg medetomidine (Nippon Zenyaku Kogyo Co., Ltd, Fukushima, Japan), 4 mg/kg midazolam (Sandoz K.K., Yamagata, Japan) and 5 mg/kg butorphanol (Meiji Seika Pharma Co., Ltd., Tokyo, Japan).
Animal ethics statement
All animal experiments were approved by the Animal Care Committee of Tokushima University (Approval No. T29-50) (Tokushima, Japan). All the animal experimental protocols used in this study was conducted in accordance with the guidelines established by the institutional ethics committee of laboratory animals.
Cell isolation and culture
All molars of the four quadrants were carefully extracted from the 4–5-week-old male SD rats under a dissection microscope (ZEISS Stemi 508, stereo microscope). The extracted teeth were immediately immersed in Dulbecco’s modified Eagle’s medium (DMEM (High glucose), Nacalai Tesque, Inc. Kyoto, Japan), supplemented with 10% fetal bovine serum (FBS, Biowest, Ireland) and 1% antibiotic solution (penicillin-streptomycin mixed solution, Nacalai Tesque, Inc. Kyoto, Japan). Following extraction, the teeth were washed thrice with phosphate buffered saline (PBS, Takara bio Inc. Shiga, Japan) and then dispersed in 3 mg/mL Collagenase type I solution (Gibco, Grand Island, NY 14072, USA) for 30 minutes at 37 °C and the tube was slightly tapped every 5 minutes. An equal amount of culture medium was added and the supernatant collected in another tube. The cells were washed and collected 3 times using the culture medium. Centrifugation was performed at 4 degrees and 1800 rpm for 3 minutes. Finally, the culture medium containing suspended PDL cells was cultured in a 35 mm dish. PDL cells between passage 3 and 5 were used for cell sheet fabrication.
Identification of PDL and MC3T3-E1 cells
The cell morphology was examined under a light microscope (Leica DMi 1, Wetzlar, Germany). Semi-quantitative PCR was performed to identify the genes related to each cell type. Total RNA was isolated from the cell cultures using a GenElute™ Mammalian Total RNA Miniprep Kit (Sigma Aldrich, Inc, USA). cDNA was then synthesized from 1 µg of the total RNA using a ReverTra Ace® qPCR RT Kit (Toyobo, Osaka, Japan). A PCR procedure was performed with GoTaq® Green Master Mix, 2× (Promega, Madison, WI USA) using the manufacturer’s protocol. PDL cells were identified for the gene expression of Col3a1, β-actin, Col1a2, GDF-7, scleraxis, periostin, tenascin C, fibronectin 1, β1-Integrin, CAP, f-spondin, Runx-2, OCN and ALP. MC3T3-E1 cells were identified for the gene expression of Col3a1, β-actin, Col1a2, GDF-7, periostin, tenascin C, fibronectin 1, β1-Integrin, CAP, f-spondin, Runx-2, OCN and ALP. All of the primers were designed using Bioinformatics, Primer3Plus software. The primer sequences are listed in Table 1. The PCR products were then checked by electrophoresis in 2% agarose gel with ethidium bromide.
Table 1.
No | Gene | Primer Sequence | Product size(BP) |
---|---|---|---|
1. | Col3a1 |
Forward 5′ AAGAGCGGAGAATACTGGG3′ Reverse 5′ CAATGTCATAGGGTGCGATA3' |
532 |
2. | β−actin |
Forward 5′ GCCAACCGTGAAAAGATGAC3′ Reverse 5′ GCTCGAAGTCTAGGGCAACA3′ |
334 |
3. | Col1a2 |
Forward 5′ CTCGCTCACAGCCTTCACTC3′ Reverse 5′ GCTGAGTTGCCATTTCCTTG3' |
396 |
4. | GDF-7 |
Forward 5′ GCCCCATCAGCATCCTCTAC3′ Reverse 5′ CAACGTCAGCAAACGAACAC3′ |
330 |
5. | Scleraxis |
Forward 5′ GACCGCACCAACAGCGTGAA3′ Reverse 5′ GTGGACCCTCCTCCTTCTAACTTC3' |
382 |
6. | Periostin |
Forward 5′ CAAACCACTTTCACGGACCT3′ Reverse 5′ CAGTTTTTCGTGCAGGGACT3′ |
369 |
7. | Tenascin C |
Forward 5′ GTGGATGGATCGTTTTCCTG3′ Reverse 5′ TGGCTGAGTCTGTGTCCTTG3' |
336 |
8. | Fibronectin 1 |
Forward 5′ CCTTAAGCCTTCTGCTCTGG 3′ Reverse 5′ CGGCAAAAGAAAGCAGAACT 3′ |
301 |
9. | β1−Integrin |
Forward 5′ GGAGGAATGTAACACGACTGC3′ Reverse 5′ CAGATGAACTGAAGGACCACC3′ |
701 |
10. | CAP |
Forward 5′ TGGTGCTTTTTCTGGTCTCC3′ Reverse 5′ CGTCCTTCTCTACGATCACCTC3' |
360 |
11. | f-spondin |
Forward 5′ CTGTAATCCCAGCACTTTGG3′ Reverse 5′ GGTTCAAGCGATTCTTCTGC3' |
343 |
12. | ALP |
Forward 5′ CTACGCACCCTGTTCTGAGG3′ Reverse 5′ ATGATGGTTGCAGGGTCTGG3' |
328 |
13. | Runx-2 |
Forward 5′ GGCCAGGTTCAACGATCTGA3′ Reverse 5′ GGTGGGGAGGATTGTGTCTG3' |
351 |
14. | OCN |
Forward 5′ AAGTCCCACACAGCAACTCG3′ Reverse 5′ GAAGCCAATGTGGTCCGCTA3' |
301 |
15. | Col3a1 |
Forward 5′ TGGCAACCCTGGAATAGCTG3 Reverse 5′ GGGTTTCCATCCCTTCCAGG3′ |
306 |
16. | β−Actin |
Forward 5′ATCGTGCGTGACATCAAAGA3′ Reverse 5′GTACTTGCGCTCAGGAGGAG3′ |
390 |
17. | Col1a2 |
Forward 5′ AAAGGCGTGAAAGGACACAG3′ Reverse 5′ GACCTGGAAGACCCACTTCA3' |
340 |
18. | GDF-7 |
Forward 5′ GAACCAGACAGGGACAGTGC3′ Reverse 5′ CCCGGAACAGACTCTCTTTCC3' |
355 |
19. | Periostin |
Forward 5′ AACCACTTTCACCGACCTGG3′ Reverse 5′ ATGGCACCATTCCTTCCCTG3' |
312 |
20. | Tenascin C |
Forward 5′ CCACCCACTACTCAGCAAGG3′ Reverse 5′ TCCAAACCCAGCAGCATAGG3' |
302 |
21. | Fibronectin 1 |
Forward 5′ GAGAACCAGGAGAGCACACC3′ Reverse 5′ AGAGGATTGCTTTCCCTGCC3' |
314 |
22. | β1−Integrin |
Forward 5′ AGTGCCATGAGGGAAATGGG3′ Reverse 5′ CAAACACGACACCTGCACAC3' |
310 |
23. | CAP |
Forward 5′ CGGGTGGTTGGTTCTTGCTA3′ Reverse 5′ TTGTACTTGTTGGGAAGCCGT3' |
352 |
24. | f-spondin |
Forward 5′ AATGTGAGAGCAGCACCCTC3′ Reverse 5′ GTGATGGACCCACCTTCTGG3' |
308 |
25. | ALP |
Forward 5′ TTCTTCTTGCTGGTGGAAGG3′ Reverse 5′ CTGGGCCTGGTAGTTGTTGT3' |
353 |
26. | Runx-2 |
Forward 5′ AATGATGGTGTTGACGCTGA3′ Reverse 5′ TTGACGGTTTGTTCCTTGGT3′ |
323 |
27. | OCN |
Forward 5′ CCCAGACCTAGCAGACACCA3′ Reverse 5′ CTTGCAGGGCAGAGAGAGAG3' |
400 |
Fabrication, histology and immunohistochemistry of cell sheets
Cell sheets were prepared using a temperature responsive culture dish (24 well culture dish, CellSeed, UpCell®, Tokyo, Japan). Three types of cell sheets were used for the study (Supplementary data, Fig. S1): two single cell sheets containing either PDL cells (PDL cell sheet) or MC3T3-E1 cells (MC3T3-E1 cell sheet) and a complex cell sheet containing both cells. The MC3T3-E1 cell sheet was fabricated at a seeding density of 1 × 106 cells per well and cultured in α-minimum essential medium (α-MEM) (Nacalai Tesque, Inc. Kyoto, Japan) with 10% FBS and 1% antibiotics. After 2 days, the medium was changed to osteogenic induction medium containing α-MEM supplemented with 10% FBS, 10 nM dexamethasone (Sigma Aldrich, Inc, USA), 50 µg/ml ascorbic acid (Sigma Aldrich, Inc, USA) and 5 Mm β-glycerophosphate (Sigma Aldrich, Inc, USA) for 2 more days. After 3–5 days, the cell sheets were collected. The PDL cell sheet was made by seeding 1 × 106 PDL cells per well and culturing in DMEM supplemented with 10% FBS and 1% antibiotic solution for up to 48 hours. The complex cell sheet was fabricated by layering PDL cells on top of the MC3T3-E1 cell culture. Firstly, the MC3T3-E1 cell sheet was cultured at a seeding density of 5 × 105 cells per well and cultured in α-MEM supplemented with 10% FBS and 1% antibiotics. After 2 days, the medium was changed to osteogenic induction medium containing α-MEM supplemented with 10% FBS, 10 nM dexamethasone, 50 µg/ml ascorbic acid and 5 mM β-glycerophosphate for 2 more days. The culture well was then carefully washed once with warm PBS to remove the osteogenic induction medium. 1 × 106 PDL cells were plated on top of the MC3T3-E1 cell sheet in the same temperature responsive culture wells. Complex cell sheets were grown in DMEM supplemented with 10% FBS and 1% antibiotic solution for up to 48 hours. All the cell sheets were harvested by reducing the temperature.
After overnight fixation in a 4% paraformaldehyde phosphate buffer solution (Nacalai Tesque, Inc. Kyoto, Japan), cell sheets were embedded in paraffin and cut into 5 µm sections. The samples were dewaxed, rehydrated and stained with hematoxylin-eosin (H&E) for morphological observation. For immunohistochemical analysis, cell sheet sections were dewaxed and dehydrated using graded concentrations of ethanol. The samples were then immersed in a combined solution of 0.3% H2O2 in methanol for 30 minutes. The samples were washed with Tris-buffered saline (TBS, pH 7.6). To avoid any non-specific binding, samples were blocked with Protein Block Serum-Free (Dako) for 30 minutes. The sections were incubated overnight with the primary anti-mouse-OCN antibody (1:200) (Abcam, Tokyo, Japan). Further processing of immunohistochemistry was performed using the Vectastain ABC kit (rabbit IgG; Vector Laboratories). The antigen reaction was visualized using a 3,3-diaminobenzidine (DAB; Sigma-Aldrich, Tokyo, Japan) chromogenic substrate, counterstained with Mayer’s hematoxylin and observed under a light microscope.
Fluorescent in situ hybridization (FISH) for complex cell sheet
FISH technique was performed according to the manufacturers protocol. Briefly, the paraffin sections were dewaxed, rehydrated, then incubated in 0.5% pepsin/0.1 N HCL solution at 37 °C for 10 minutes. The slides were then washed in PBS once, followed by alcohol dehydration. The probe (SPR-20, species specific FISH probe, Rat (Cy3) (CSL, Chromosome science, Japan) was applied to the specimen and incubated at 80 °C for 10 minutes, followed by overnight hybridization at 37 °C. The following day, slide was immersed in 2X saline sodium citrate buffer (2X SSC), then incubated in 50% formamide/ 2X SSC at 37 °C for 20 minutes. Finally, the slide was mounted using Fluoro-KEEPER Antifade Reagent, Non-Hardening Type with DAPI (Nacalai Tesque, Kyoto, Japan) and fluorescence detection were performed using a Nikon A1 laser scanning confocal microscope (Nikon Instruments Inc. Melville, U.S.A).
Alizarin red staining of complex cell sheets
Following overnight fixation in a 4% paraformaldehyde phosphate buffer solution (Nacalai Tesque, Inc. Kyoto, Japan), cell sheets were embedded in paraffin and cut into 5 µm sections. The samples were dewaxed, rehydrated and stained with stained with 1% Alizarin red solution (Muto Pure Chemicals Co., Japan) for 10 min and analyzed under light microscope.
Ectopic transplantation
The PDLs on the extracted mice mandibular first molar teeth were removed using enzymatic digestion with collagenase type I solution, and were then autoclaved to remove the remnants of any cells in the tooth (Supplementary data, Fig. S2). These teeth were used as a carrier for ectopic transplantation of the cell sheets. CB17/Icr-scid/scid female mice were used as a host for subrenal capsule transplantation. Cell sheets were sectioned into 4 pieces and each section was wrapped around the mice mandibular first molar roots. This tooth cell sheet complex was inserted into collagen gel (Cellmatrix®, Nitta Gelatin Inc.) and incubated at 37 °C for 20 minutes to coagulate the collagen gel. Subrenal capsule transplantation of the cell sheet unit was performed as described previously71. All samples were transplanted into the subrenal capsule of immunocompromised mice with each mice receiving 4 transplants. PDL cells side of the complex cell sheet were facing the root surface. The procedure was carried out under a dental microsurgery microscope (Leica M 320 F 12). The transplants were collected after 4 weeks (Supplementary data, Fig. S2).
Orthotopic transplantation
A periodontal tissue injury defect in CB17/Icr-scid/scid female mice were used. A small incision was made from the mesial side of the maxillary first molar and the palatal mucosa was gently elevated up to the maxillary second molar. The periodontal tissue injury was created on the palatal bone overlying the maxillary first molars using a small round carbide burr (ZIPPER carbide burr, HP 1/4) at a slow speed. The procedure was carried out under a dental microsurgery microscope (Leica M 320 F 12). The injury was carefully created by removing the bone and PDL adjacent to the maxillary first molar tooth without trimming the root. The defect was created from the cervical portion of the crown and the palatal roots were exposed (Fig. 6B (shown by red arrows) & Fig. S3A,B). The defect area was irrigated with abundant PBS and wiped using sterile cotton rolls. Cell sheets were trimmed to the appropriate shape and adapted to the exposed root surface. As we explained in the ectopic transplantation, the PDL cell side of complex cell sheet was facing towards the root surface and the MC3T3-E1 cell side towards the bone tissue side. The mucosa was sutured back in position with 8-0 nylon (Bear medic, Chiba, Japan).
Microcomputed radiographic imaging and bone regeneration volume analysis using micro computed tomography (micro-CT)
After 8 weeks of orthotopic transplantation, all animals were sacrificed by cervical dislocation. Surgical sites were dissected, washed once in PBS and then fixed in 4% paraformaldehyde phosphate buffer solution for 2 days and analyzed using micro-CT with SkyScan 1176 (SkyScan, Kontich, Belgium). Scanning was performed at 65 kV and 380 µA at a reconstruction angular range of 360° under a voxel size of 9 µM. The scanned images were reconstructed using NRecon software (Bruker micro CT, Kontich, Belgium). Three-dimensional modeling analysis of reconstructed images were carried out using CTVox software (Bruker micro CT, Kontich, Belgium). Region of interest (ROI) was selected from the palatal bone adjacent to the first molar tooth on right and left side (Fig. S3C,D, is indicated in blue color) and regenerated bone volume at the injury site was analyzed and quantified using CT analyzer software (CTAn, Bruker micro CT, Kontich, Belgium).
Histological and immunohistochemical analysis of transplants
Ectopic and orthotopic transplant samples were decalcified in 8% ethylene diamine tetracetic acid (EDTA) solution for 3–4 weeks. After decalcification, samples were embedded in paraffin for 5 µm histologic sectioning. For histologic analysis, ectopic and orthotopic transplant sections were stained with H&E or azan staining. For immunohistochemical analysis, ectopic and orthotopic transplant tissue sections were dewaxed and dehydrated using graded concentrations of ethanol. The samples were then immersed in a combined solution of 0.3% H2O2 in methanol for 30 minutes. The samples were washed with Tris-buffered saline (TBS, pH 7.6). To avoid any non-specific binding, samples were blocked with Protein Block Serum-Free (Dako) for 30 minutes. The sections were incubated overnight with the primary anti-periostin antibody (1:500) (Abcam, Tokyo, Japan) or anti-mouse-OCN antibody (1:200) (Abcam, Tokyo, Japan). Further processing of immunohistochemistry was performed using the Vectastain ABC kit (rabbit IgG; Vector Laboratories). The antigen reaction was visualized using a 3,3-diaminobenzidine (DAB; Sigma-Aldrich, Tokyo, Japan) chromogenic substrate, counterstained with Mayer’s hematoxylin and observed under a light microscope (OlympusBX50 upright microscope, DP70 microscope digital camera, Tokyo, Japan).
Statistical analysis
The experimental values were expressed as means ± SD. Statistical significance was evaluated by one-way ANOVA followed by the Tukey HSD test. The significance level was set at P < 0.05.
Supplementary information
Acknowledgements
This work was supported by the Kurata Grants from The Hitachi Global Foundation. This work was partially supported by Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (C), Grant Number JP19K10208. Our sincere thanks to Otsuka Toshimi Scholarship Foundation for financially supporting Resmi Raju during the course of this research. We thank Dr. Keiko Miyoshi and Dr. Dian Yosi Arinawati from the department of Molecular Biology, Tokushima University for the valuable advice and suggestions during the course of this study. We thank Ashleigh Cooper, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.
Author contributions
M.O. and Y.M. is responsible for the study design and protocol. R.R. and M.O. prepared the cell sheets and carried out ectopic and orthotopic transplantation. M.I., Miho.I., A.W. and R.R. performed immunohistochemistry, azan staining and analysis. R.R., O.B., Miho.I. and T.M. performed the H&E staining and analysis. R.R., Y.H., A.W. and T.M. did the micro-CT scanning and analysis. R.R. and M.O. wrote the article and all other co-authors discussed the results and approved the final version of the manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-020-58222-0.
References
- 1.Yang Y, Rossi FMV, Putnins EE. Periodontal regeneration using engineered bone marrow mesenchymal stromal cells. Biomater. 2010;31:8574–8582. doi: 10.1016/j.biomaterials.2010.06.026. [DOI] [PubMed] [Google Scholar]
- 2.Seo BM, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004;364:149–155. doi: 10.1016/S0140-6736(04)16627-0. [DOI] [PubMed] [Google Scholar]
- 3.Shimono M, et al. Regulatory mechanisms of periodontal regeneration. Microsc. Res. Tech. 2003;60:491–502. doi: 10.1002/jemt.10290. [DOI] [PubMed] [Google Scholar]
- 4.Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820. doi: 10.1016/S0140-6736(05)67728-8. [DOI] [PubMed] [Google Scholar]
- 5.Dan H, et al. The influence of cellular source on periodontal regeneration using calcium phosphate coated polycaprolactone scaffold supported cell sheets. Biomater. 2014;35:113–122. doi: 10.1016/j.biomaterials.2013.09.074. [DOI] [PubMed] [Google Scholar]
- 6.Magnusson I, Runstad L, Nyman S, Lindhe J. A long junctional epithelium - A locus minoris resistentiae in plaque infection? J. Clin. Periodontol. 1983;10:333–340. doi: 10.1111/j.1600-051x.1983.tb01282.x. [DOI] [PubMed] [Google Scholar]
- 7.Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J. New attachment formation in the human periodontium by guided tissue regeneration. Case reports. J. Clin. Periodontol. 1986;13:604–616. doi: 10.1111/j.1600-051x.1986.tb00854.x. [DOI] [PubMed] [Google Scholar]
- 8.Nyman S, Gottlow J, Lindhe J, Karring T, Wennstrom J. New attachment formation by guided tissue regeneration. J. Periodont Res. 1987;22:252–254. doi: 10.1111/j.1600-0765.1987.tb01581.x. [DOI] [PubMed] [Google Scholar]
- 9.Ikeda E, Tsuji T. Growing bioengineered teeth from single cells: potential for dental regenerative medicine. Expert. Opin. Biol. Ther. 2008;8:735–744. doi: 10.1517/14712598.8.6.735. [DOI] [PubMed] [Google Scholar]
- 10.Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nat. 2008;451:937–942. doi: 10.1038/nature06800. [DOI] [PubMed] [Google Scholar]
- 11.Korbling M, Estrov Z. Adult stem cells for tissue repair—a new therapeutic concept? N. Engl. J. Med. 2003;349:570–82. doi: 10.1056/NEJMra022361. [DOI] [PubMed] [Google Scholar]
- 12.Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nat. 2008;453:314–21. doi: 10.1038/nature07039. [DOI] [PubMed] [Google Scholar]
- 13.Chen FM, Sun HH, Lu H, Yu Q. Stem cell-delivery therapeutics for periodontal tissue regeneration. Biomater. 2012;33:6320–6344. doi: 10.1016/j.biomaterials.2012.05.048. [DOI] [PubMed] [Google Scholar]
- 14.Javier C, Nagihan B, Eumorphia R, Cosimo DB, Thimios AM. Future dentistry: cell therapy meets tooth and periodontal repair and regeneration. J. Cell Mol. Med. 2011;15:1054–1065. doi: 10.1111/j.1582-4934.2010.01251.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yang Z, et al. Tissue engineering of cementum/periodontal-ligament complex using a novel three-dimensional pellet cultivation system for human periodontal ligament stem cells. Tissue Eng. Part. C. Methods. 2009;15:571–581. doi: 10.1089/ten.tec.2008.0561. [DOI] [PubMed] [Google Scholar]
- 16.Saito M, et al. Immortalization of cementoblast progenitor cells with Bmi-1 and TERT. J. Bone Min. Res. 2005;20:50–57. doi: 10.1359/JBMR.041006. [DOI] [PubMed] [Google Scholar]
- 17.Morsczeck C, et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol. 2005;24:155–165. doi: 10.1016/j.matbio.2004.12.004. [DOI] [PubMed] [Google Scholar]
- 18.Luan Xianghong, Ito Yoshihiro, Dangaria Smit, Diekwisch Thomas G.H. Dental Follicle Progenitor Cell Heterogeneity in the Developing Mouse Periodontium. Stem Cells and Development. 2006;15(4):595–608. doi: 10.1089/scd.2006.15.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mitrano TI, et al. Culture and Characterization of Mesenchymal Stem Cells From Human Gingival Tissue. J. Periodontol. 2010;81:917–925. doi: 10.1902/jop.2010.090566. [DOI] [PubMed] [Google Scholar]
- 20.Tang L, Li N, Xie H, Jin Y. Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J. Cell. Physiol. 2011;226:832–842. doi: 10.1002/jcp.22405. [DOI] [PubMed] [Google Scholar]
- 21.Fawzy El-Sayed KM, et al. Periodontal regeneration employing gingival margin-derived stem/progenitor cells: An animal study. J. Clin. Periodontol. 2012;39:861–870. doi: 10.1111/j.1600-051x.2012.01904.x. [DOI] [PubMed] [Google Scholar]
- 22.Hyun S, Lee J, Kang K, Jang Y. Effect of FGF-2, TGF-β-1, and BMPs on teno/ligamentogenesis and osteo/cementogenesis of human periodontal ligament stem cells. Mol. Cell. 2017;40:550–557. doi: 10.14348/molcells.2017.0019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Addin AS, Hoshi TAS, Ikawa TMT, Matsui SFM, Izumi YTY. Biodegradable gelatin/betaitricalcium phosphate sponges incorporating recombinant human fibroblast growth factor‐2 for treatment of recession‐type defects: A split‐mouth study in dogs. J. Periodont Res. 2017;52:863–871. doi: 10.1111/jre.12456. [DOI] [PubMed] [Google Scholar]
- 24.Kono K, Maeda H, Fujii S. Exposure to transforming growth factor- β 1 after basic fibroblast growth factor promotes the fibroblastic differentiation of human periodontal ligament stem / progenitor cell lines. Cell Tissue Res. 2013;352:249–263. doi: 10.1007/s00441-012-1543-0. [DOI] [PubMed] [Google Scholar]
- 25.Masaeli R, Zandsalimi K, Lotfi Z, Tayebi L. Using enamel matrix derivative to improve treatment efficacy in periodontal furcation defects. J. Prosthodont. 2018;27:733–736. doi: 10.1111/jopr.12753. [DOI] [PubMed] [Google Scholar]
- 26.Shujaa Addin A, et al. Histological healing after nonsurgical periodontal treatment with enamel matrix derivatives in canine experimental periodontitis. Odontology. 2018;106:289–296. doi: 10.1007/s10266-018-0347-4. [DOI] [PubMed] [Google Scholar]
- 27.Gault P, et al. Tissue-engineered ligament: implant constructs for tooth replacement. J. Clin. Periodontol. 2010;37:750–758. doi: 10.1111/j.1600-051x.2010.01588.x. [DOI] [PubMed] [Google Scholar]
- 28.Diomede F, et al. Human periodontal ligament stem cells cultured onto cortico-cancellous scaffold drive bone regenerative process. Eur. Cell Mater. 2016;32:181–201. doi: 10.22203/ecm.v032a12. [DOI] [PubMed] [Google Scholar]
- 29.Carmagnola D, Tarce M, Dellavia C, Rimondini L, Varoni EM. Engineered scaffolds and cell-based therapy for periodontal regeneration. J. Appl. Biomater. Funct. Mater. 2017;15:e303–e312. doi: 10.5301/jabfm.5000389. [DOI] [PubMed] [Google Scholar]
- 30.Yamato M, Okano T. Cell sheet engineering. Mater. Today. 2004;7:42–47. doi: 10.1016/S1369-7021(04)00234-2. [DOI] [Google Scholar]
- 31.Nagase K, Yamato M, Kanazawa H, Okano T. Poly(N-isopropylacrylamide)-based thermoresponsive surfaces provide new types of biomedical applications. Biomater. 2018;153:27–48. doi: 10.1016/j.biomaterials.2017.10.026. [DOI] [PubMed] [Google Scholar]
- 32.Iwata T, Yamato M, Washio K, Yoshida T. Periodontal regeneration with autologous periodontal ligament- derived cell sheets- A safety and efficacy study in ten patients. Regen. Ther. 2018;9:38–44. doi: 10.1016/j.reth.2018.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhu B, et al. Tissue-specific composite cell aggregates drive periodontium tissue regeneration by reconstructing a regenerative microenvironment. J. Tissue Eng. Regen. Med. 2017;11:1792–1805. doi: 10.1002/term.2077. [DOI] [PubMed] [Google Scholar]
- 34.Vaquette C, et al. A biphasic scaffold design combined with cell sheet technology for simultaneous regeneration of alveolar bone / periodontal ligament complex. Biomater. 2012;33:5560–5573. doi: 10.1016/j.biomaterials.2012.04.038. [DOI] [PubMed] [Google Scholar]
- 35.Bai Y, et al. Cementum- and periodontal ligament-like tissue formation by dental follicle cell sheets co-cultured with hertwig’s epithelial root sheath cells. Bone. 2011;48:1417–1426. doi: 10.1016/j.bone.2011.02.016. [DOI] [PubMed] [Google Scholar]
- 36.Iwata T, et al. Periodontal regeneration with multi-layered periodontal ligament-derived cell sheets in a canine model. Biomater. 2009;30:2716–2723. doi: 10.1016/j.biomaterials.2009.01.032. [DOI] [PubMed] [Google Scholar]
- 37.Chen FM, et al. A review on endogenous regenerative technology in periodontal regenerative medicine. Biomater. 2010;31:7892–7927. doi: 10.1016/j.biomaterials.2010.07.019. [DOI] [PubMed] [Google Scholar]
- 38.Yang J, et al. Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomater. 2005;26:6415–6422. doi: 10.1016/j.biomaterials.2005.04.061. [DOI] [PubMed] [Google Scholar]
- 39.Ebihara G, et al. Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model. Biomater. 2012;33:3846–3851. doi: 10.1016/j.biomaterials.2012.01.056. [DOI] [PubMed] [Google Scholar]
- 40.Ohki T, et al. Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut. 2006;55:1704–1710. doi: 10.1136/gut.2005.088518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Haraguchi Y, Shimizu T, Yamato M, Kikuchi A, Okano T. Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomater. 2006;27:4765–4774. doi: 10.1016/j.biomaterials.2006.04.034. [DOI] [PubMed] [Google Scholar]
- 42.Matsumoto E, et al. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine. PLoS One. 2019;14:Article e0212369. doi: 10.1371/journal.pone.0212369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hayashi R, et al. Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells. Nat. Protoc. 2017;12:683–696. doi: 10.1038/nprot.2017.007. [DOI] [PubMed] [Google Scholar]
- 44.Murakami Y, Kojima T, Nagasawa T, Kobayashi H, Ishikawa I. Novel isolation of alkaline phosphatase-positive subpopulation from periodontal ligament fibroblasts. J. Periodontol. 2003;74:780–86. doi: 10.1902/jop.2003.74.6.780. [DOI] [PubMed] [Google Scholar]
- 45.Lekic P, Rojas J, Birek C, Tenenbaum H, McCulloch CA. Phenotypic comparison of periodontal ligament cells in vivo and in vitro. J. Periodontal Res. 2001;36:71–79. doi: 10.1034/j.1600-0765.2001.360202.x. [DOI] [PubMed] [Google Scholar]
- 46.Oshima, M. et al. Functional tooth restoration by next-generation bio-hybrid implant as a bio-hybrid artificial organ replacement therapy. Sci. Rep. 4, 6044, 10.1038/srep06044 (2014). [DOI] [PMC free article] [PubMed]
- 47.Zhu B, et al. Jawbone microenvironment promotes periodontium regeneration by regulating the function of periodontal ligament stem cells. Sci. Rep. 2017;7:40088. doi: 10.1038/srep40088. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 48.Zhang H, et al. Composite cell sheet for periodontal regeneration: crosstalk between different types of MSCs in cell sheet facilitates complex periodontal-like tissue regeneration. Stem Cell Res. Ther. 2016;7:168. doi: 10.1186/s13287-016-0417-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Lee, D.J. et al. Bio-implant as a novel restoration for tooth loss. Sci. Rep. 7, 7414, 10.1038/41598-017-07819-z (2017). [DOI] [PMC free article] [PubMed]
- 50.Bratt-Leal Andrés M., Carpenedo Richard L., Ungrin Mark D., Zandstra Peter W., McDevitt Todd C. Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials. 2011;32(1):48–56. doi: 10.1016/j.biomaterials.2010.08.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Han J, Menicanin D, Gronthos S, Bartold PM. Stem cells, tissue engineering and periodontal regeneration. Aust. Dent. J. 2014;59:117–130. doi: 10.1111/adj.12100. [DOI] [PubMed] [Google Scholar]
- 52.Yang JW, et al. Autophagy in SDF-1α-mediated DPSC migration and pulp regeneration. Biomater. 2015;44:11–23. doi: 10.1016/j.biomaterials.2014.12.006. [DOI] [PubMed] [Google Scholar]
- 53.Sasagawa T, et al. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomater. 2010;31:1646–1654. doi: 10.1016/j.biomaterials.2009.11.036. [DOI] [PubMed] [Google Scholar]
- 54.Shimizu H, et al. Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus. Biomater. 2009;30:5943–5949. doi: 10.1016/j.biomaterials.2009.07.042. [DOI] [PubMed] [Google Scholar]
- 55.Park CH, et al. Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomater. 2012;33:137–145. doi: 10.1016/j.biomaterials.2011.09.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Lee Chang H., Hajibandeh Jeffrey, Suzuki Takahiro, Fan Andrew, Shang Peng, Mao Jeremy J. Three-Dimensional Printed Multiphase Scaffolds for Regeneration of Periodontium Complex. Tissue Engineering Part A. 2014;20(7-8):1342–1351. doi: 10.1089/ten.tea.2013.0386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Duan X, et al. Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. J. Cell. Physiol. 2011;226:150–157. doi: 10.1002/jcp.22316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Wada N, et al. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J. Periodontal Res. 2011;46:438–447. doi: 10.1111/j.1600-0765.2011.01358.x. [DOI] [PubMed] [Google Scholar]
- 59.Liu Jun, Chen Wenchuan, Zhao Zhihe, Xu Hockin H.K. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering. Biomaterials. 2013;34(32):7862–7872. doi: 10.1016/j.biomaterials.2013.07.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wang P., Zhao L., Chen W., Liu X., Weir M.D., Xu H.H.K. Stem Cells and Calcium Phosphate Cement Scaffolds for Bone Regeneration. Journal of Dental Research. 2014;93(7):618–625. doi: 10.1177/0022034514534689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.TheinHan WahWah, Liu Jun, Tang Minghui, Chen Wenchuan, Cheng Linzhao, Xu Hockin H. K. Induced Pluripotent Stem Cell-derived Mesenchymal Stem Cell Seeding on Biofunctionalized Calcium Phosphate Cements. Bone Research. 2013;1(4):371–384. doi: 10.4248/BR201304008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Yang Heng, Aprecio Raydolfo M., Zhou Xiaodong, Wang Qi, Zhang Wu, Ding Yi, Li Yiming. Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study. PLoS ONE. 2014;9(6):e100285. doi: 10.1371/journal.pone.0100285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Duan Xuejing, Tu Qisheng, Zhang Jin, Ye Jinhai, Sommer Cesar, Mostoslavsky Gustavo, Kaplan David, Yang Pishan, Chen Jake. Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. Journal of Cellular Physiology. 2010;226(1):150–157. doi: 10.1002/jcp.22316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Hynes K., Menicanin D., Han J., Marino V., Mrozik K., Gronthos S., Bartold P.M. Mesenchymal Stem Cells from iPS Cells Facilitate Periodontal Regeneration. Journal of Dental Research. 2013;92(9):833–839. doi: 10.1177/0022034513498258. [DOI] [PubMed] [Google Scholar]
- 65.Yin X, et al. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 2016;473:726–732. doi: 10.1016/j.bbrc.2015.10.012. [DOI] [PubMed] [Google Scholar]
- 66.Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell Biol. 2008;9:725–729. doi: 10.1038/nrm2466. [DOI] [PubMed] [Google Scholar]
- 67.Miyahara Y, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006;12:459–465. doi: 10.1038/nm1391. [DOI] [PubMed] [Google Scholar]
- 68.Ohashi K, et al. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat. Med. 2007;13:880–885. doi: 10.1038/nm1576. [DOI] [PubMed] [Google Scholar]
- 69.Shimizu T, et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006;20:708–710. doi: 10.1096/fj.05-4715fje. [DOI] [PubMed] [Google Scholar]
- 70.Sekine, H. et al. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat. Commun. 4, 1399, 10.1038/ncomms2406 (2013). [DOI] [PMC free article] [PubMed]
- 71.Oshima M, Ogawa M, Yasukawa M, Tsuji T. Generation of a bioengineered tooth by using a three-dimensional cell manipulation method (Organ germ method) Methods Mol. Biol. 2012;887:149–65. doi: 10.1007/978-1-61779-860-3_14. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.